Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
| 21 | DE file number | DAKZ | 60 2007 053 336.8 |
| 96 | EP file number | EAKZ | 15 18 1545.3 |
| 97 | EP publication number | EPN | 3045466 |
| 54 | Designation/title | TI | (2S,3R,4S,5S,6R)-2-[4-CHLORO-3-(4-ETHOXY-BENZYL)-PHENYL]-6-HYDROXYMETHYL-2-METHOXY-TETRAHYDRO-PYRAN-3,4,5-TRIOL PROPYLENE GLYCOL SOLVAT ALS SGT2 INHIBITOR ZUR BEHANDLUNG VON DIABETES |
| 51 | IPC main class | ICM
(ICMV) | C07H 7/04 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | C07H 15/207 (2006.01), A61K 31/7034 (2006.01), A61K 45/06 (2006.01), A61P 3/10 (2006.01) |
| 22 | DE application date | DAT | Jun 21, 2007 |
| 96 | EP application date | EAT | Jun 21, 2007 |
| 43 | Date of first publication | OT | Jul 20, 2016 |
| Date of publication of grant | PET | Dec 6, 2017 |
| 71/73 | Applicant/owner | INH | AstraZeneca AB, 15185 Södertälje, SE |
| 72 | Inventor | IN | GOUGOUTAS, Jack Z., Princeton, NJ New Jersey 08540, US; NIRSCHL, Alexandra A., Yardley, PA Pennsylvania 19067, US; SINGH, Janak, Pennington, NJ New Jersey 08534, US; DIMARCO, John D., Princeton, NJ New Jersey 08543, US; LOBINGER, Hildegard, 93059 Regensburg, DE; RAMAKRISHNAN, Srividya, Miltown, NJ New Jersey 08850, US; DESHPANDE, Prashant P., New Brunswick, NJ New Jersey 08903, US; BIEN, Jeffrey T., New Brunswick, NJ New Jersey 08903, US; LAI, Chiajen, New Brunswick, NJ New Jersey 08903, US; WANG, Chenchi, New Brunswick, NJ New Jersey 08903, US; RIEBEL, Peter, 94099 Ruhstorf A.d.Rott, DE; GROSSO, John Anthony, Princeton Junction, NJ New Jersey 08550, US |
| Address for service | | RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
765481
Jun 20, 2007
|
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
817118 P
Jun 28, 2006
|
| Due date | FT
FG | Jun 30, 2025
Annual fee for the 19th year
Patent fees |
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003045466
Searchable text:
EP000003045466
Original document:
EP000003045466B1
Searchable text:
EP000003045466B1
Original document:
EP000003045466B2
Searchable text:
EP000003045466B2 |
| 43 | Date of first publication | EVT | Jul 20, 2016 |
| Date of the first transfer into DPMAregister | EREGT | Sep 2, 2016 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 31, 2024
(Show all update days)(Hide all update days)- Oct 31, 2024
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 16.10.2024: changed
- Sep 26, 2024
- Published EP/WO documents: changed
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 16.10.2024: new
- Procedures: Opposition procedure, Patent maintained in amended form by EPO, 16.10.2024: new
- Jul 10, 2024; Apr 10, 2024; May 3, 2023; May 7, 2022; Jun 3, 2021; Jun 16, 2020; Aug 17, 2019; Jun 26, 2019; Mar 21, 2019; Nov 8, 2018; Oct 4, 2018; Jun 21, 2018; Feb 2, 2018; Dec 21, 2017; Dec 1, 2017; Nov 30, 2017; Jul 20, 2017
- Historical data not available for this/these date(s)
- Sep 2, 2016
- Date of the first transfer into DPMAregister
|
